In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly & Boehringer: When You Gotta Partner, You Gotta Partner

Executive Summary

Lilly's co-promotion with Boehringer Ingelheim of duloxetine is the first time the American company has signed a major marketing deal for one of its own products. The company notes the collaboration is part of its broad commitment to partnering and that the market is intensely competitive. But the choice of duloxetine--the launch of which may be delayed indefinitely because of manufacturing problems--also represents Lilly's lowest-risk option for subsidizing the launches, and maximizing the returns from, potentially eight new products over the next few years.
Advertisement

Related Content

Exploiting Connections and Navigating Bumps Along the Brain-Gut Axis
Lilly Icos: A Complementary Alliance
A Precarious Union: Combining Proprietary and Generic Businesses
Amylin/Lilly: Resurrections and Conversions
A Precarious Union: Combining Proprietary and Generic Businesses
Managing Alliances at Lilly
Managing Alliances at Lilly
Protein C: Saving Lives, Saving Lilly
Boehringer Ingelheim Restructures for Success
Leveraging Lilly

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel